FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Methylphenidate Hydrochloride Tablets Recall

Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manuf…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Aug 2, 2023
Recall ID
D-0940-2023
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Methylphenidate Hydrochloride Tablets starting Jul 13, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0940-2023 on Aug 2, 2023. Reason: Presence of Foreign Substance: Metal embedded in a tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: Metal embedded in a tablet.

Product description

Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 57664-230-88.

Lot numbers, UPCs & expiration codes

Lot AC74459, Exp 07/31/2024

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0940-2023
Classification
Class II
Status
Terminated
Recall initiated
Jul 13, 2023
FDA report date
Aug 2, 2023
Quantity
7313 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0940-2023, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
92680
Address
2 Independence Way
Code information
Lot AC74459, Exp 07/31/2024
Postal code
08540-6620
Report date
Aug 2, 2023
Product type
Drugs
Recall number
D-0940-2023
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
7313 bottles
Termination date
Feb 12, 2024
Reason for recall
Presence of Foreign Substance: Metal embedded in a tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 57664-230-88.
Distribution pattern
Nationwide
Recall initiation date
Jul 13, 2023
Initial firm notification
Letter
Center classification date
Jul 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0940-2023, published Aug 2, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls